Holen Sie sich die Stockscreener-App
12.84
2.58%
-0.34
Schlusskurs vom Vortag:
$13.18
Offen:
$12.9
24-Stunden-Volumen:
1.35M
Relative Volume:
0.68
Marktkapitalisierung:
$1.96B
Einnahmen:
$177.28M
Nettoeinkommen (Verlust:
$-195.24M
KGV:
-9.5821
EPS:
-1.34
Netto-Cashflow:
$-114.54M
1W Leistung:
+0.31%
1M Leistung:
+24.30%
6M Leistung:
+55.45%
1J Leistung:
+173.19%
1-Tages-Spanne:
$12.68
$13.23
1-Wochen-Bereich:
$12.63
$13.52
52-Wochen-Spanne:
$3.981
$13.52
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
12.84 | 2.01B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Visualizing Adaptive Biotechnologies Corporation stock with heatmapsJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Adaptive Biotechnologies Corporation2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Has Adaptive Biotechnologies Corporation formed a bullish divergenceExit Point & Verified Short-Term Trading Plans - Newser
Candlestick signals on Adaptive Biotechnologies Corporation stock todayJobs Report & AI Forecast Swing Trade Picks - Newser
How high can Adaptive Biotechnologies Corporation stock goMarket Risk Summary & Weekly Momentum Stock Picks - Newser
Should you wait for a breakout in Adaptive Biotechnologies CorporationM&A Rumor & AI Based Trade Execution Alerts - Newser
Developing predictive dashboards with Adaptive Biotechnologies Corporation data2025 Technical Patterns & Technical Confirmation Alerts - Newser
Is Adaptive Biotechnologies Corporation a top pick in the sectorMarket Risk Report & High Accuracy Swing Trade Signals - خودرو بانک
Does Adaptive Biotechnologies Corporation stock reflect fundamentalsWeekly Trade Summary & Reliable Price Action Trade Plans - خودرو بانک
What high frequency data says about Adaptive Biotechnologies CorporationQuarterly Profit Review & Short-Term High Return Strategies - Newser
Are You Looking for a Top Momentum Pick? Why Adaptive Biotechnologies (ADPT) is a Great Choice - Yahoo Finance
How Adaptive Biotechnologies Corporation stock reacts to Fed policy changesTrade Volume Report & Daily Entry Point Alerts - Newser
Published on: 2025-08-31 20:18:40 - Newser
Top chart patterns to watch in Adaptive Biotechnologies CorporationJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser
Will Adaptive Biotechnologies Corporation rebound enough to break evenJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser
Multi asset correlation models including Adaptive Biotechnologies CorporationWeekly Risk Report & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-30 22:39:14 - Newser
Published on: 2025-08-30 15:51:42 - Newser
Published on: 2025-08-30 15:15:44 - Newser
Market reaction to Adaptive Biotechnologies Corporation’s recent news2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser
Is it time to cut losses on Adaptive Biotechnologies CorporationQuarterly Growth Report & AI Driven Stock Reports - Newser
Price momentum metrics for Adaptive Biotechnologies Corporation explainedPortfolio Risk Summary & Low Risk Entry Point Tips - Newser
Published on: 2025-08-29 12:14:22 - Newser
Published on: 2025-08-29 11:39:06 - Newser
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Is Adaptive Biotechnologies Corporation stock ready for a breakoutJuly 2025 Short Interest & Growth Focused Entry Reports - Newser
Published on: 2025-08-29 12:12:27 - Newser
Is Adaptive Biotechnologies Corporation a candidate for recovery playBond Market & Real-Time Stock Movement Alerts - Newser
Regression analysis insights on Adaptive Biotechnologies Corporation performanceBond Market & Weekly Momentum Stock Picks - Newser
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):